Clinical Trials List
2024-07-15 - 2026-08-31
Phase I
Recruiting4
ICD-10C34.90
Malignant neoplasm of unspecified part of unspecified bronchus or lung
ICD-10C34.91
Malignant neoplasm of unspecified part of right bronchus or lung
ICD-10C34.92
Malignant neoplasm of unspecified part of left bronchus or lung
ICD-10C7A.090
Malignant carcinoid tumor of the bronchus and lung
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.9
Malignant neoplasm of bronchus and lung, unspecified
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 楊宏志 無
- JA-DER LIANG 無
- Chun-Jen Liu 無
- 施怡倫 無
- KAI-WEN HUANG 無
- Chih-Hung Hsu 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yi-Ping Hung 無
- Yung-Hung Luo 無
- Chi-Lu Chiang 無
- 唐振育 無
- Hao-Wei Teng 無
- 姜乃榕 無
- San-Chi Chen 無
- Jiun-I Lai 無
- Chien-An Liu 無
- Tien-Hua Chen 無
- Chueh-Chuan Yen 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Shang-Yin Wu 無
- Chin-Wei Kuo 無
- Seu-Chun Yang 無
- Chun-Hui Lee 無
- Shang-Hung Chen 無
- Yu-Min Yeh 無
- Chian-Wei Chen 無
- 蔡政軒 無
- Chiu Hung Chiu 無
- Yu-Fang Huang 無
- Wu-Chou Su 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
25 participants
-
Global
257 participants
